You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 32 No. 9, September 1975 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Alzheimer Degeneration in Down Syndrome

Electrophysiologic Alterations and Histopathologic Findings

Donald R. Crapper, MD, FRCP (C); Arthur J. Dalton, PhD; Macey Skopitz, P Eng; John W. Scott, MD; Vladimir C. Hachinski, MD, FRCP (C)

Arch Neurol. 1975;32(9):618-623.


Abstract

• Progressive electroencephalographic disorganization and decreased voltage amplitude in the late components of the averaged visual evoked potentials were recorded in the last two years of life of a patient with Down disease and Alzheimer degeneration. Taken together with quantitative histopathologic findings, the electrophysiologic alterations are interpreted in terms of recent evidence from an experimental animal model of dementia. Neurons with neurofibrillary degeneration become electrically inactive and contribute to the loss of voltage generators associated with neuron death in Alzheimer disease. Loss of voltage generators may result in disfacilitation and disinhibition of surviving neurons, thus causing the loss of normal rhythms.



Author Affiliations

From the departments of physiology and medicine, University of Toronto, Toronto (Drs. Crapper, Scott, and Hachinski, and Mr. Skopitz) and the Surrey Place Centre, Toronto (Dr. Dalton).


Footnotes

Accepted for publication Sept 17, 1974.

Reprint requests to Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, Canada (M5S-1A8) (Dr. Crapper).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Relation of EEG Alpha Background to Cognitive Function, Brain Atrophy, and Cerebral Metabolism in Down's Syndrome: Age-Specific Changes
Devinsky et al.
Arch Neurol 1990;47:58-62.
ABSTRACT  

Alzheimer's disease: a disorder of cortical cholinergic innervation
Coyle et al.
Science 1983;219:1184-1190.
ABSTRACT  

Myoclonus in Down's Syndrome: Association With Alzheimer's Disease
Blumbergs et al.
Arch Neurol 1981;38:453-454.
ABSTRACT  

The Genetics of Alzheimer's Disease: Associations With Hematologic Malignancy and Down's Syndrome
Heston and Mastri
Arch Gen Psychiatry 1977;34:976-981.
ABSTRACT  

Alzheimer's Disease, Trisomy 21, and Myeloproliferative Disorders: Associations Suggesting a Genetic Diathesis
HESTON
Science 1977;196:322-323.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.